explore -WSS

explore

author：explore 2025-09-30 23:04:27 - browse：21194

Richard Neal. -- health policy coverage from STAT — Rep. Richard Neal (D-Mass.) Drew Angerer/Getty Images

WASHINGTON — A rift between Democrats and Republicans over health care transparency was on full display in the House on Wednesday.

Republicans on the House Ways & Means Committee introduced a package this week that they say would increase health care transparency, but Democrats and outside groups are arguing that it doesn’t go far enough to force companies to disclose information about their ownership. They also think it goes too easy on the private equity firms that are buying up health care practices.

“There was an opportunity here for bipartisanship, but I think we ought to reference that in the past tense,” said ranking Democrat Richard Neal (D-Mass.).

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： Venture capital firm's plans to take over Akron hospital face hurdles

knowledge

WSS

Wegovy leads to weight loss. Can it treat depression, too?

Merck CEO won’t testify in Senate, citing no expertise in drug prices

Gilead’s Trodelvy fails in lung cancer, raises questions on ADCs

White House pharmacy plagued with problems, investigation finds

Humana’s losses in Medicare Advantage tank its stock

Biogen walks away from Aduhelm, years after polarizing approval

leisure time

explore

focus

In Memoriam: Notable people who died in 2023

Syphilis numbers in the United States reach record heights

Heart attack and stroke risk calculators need revising

Think you might have Covid

In Memoriam: Notable people who died in 2023

Medicare Advantage today, explained in one chart

Medicare details structure of new drug price negotiation program

FTC sues over Novant Health acquisition of two N.C. hospitals

At least 13 dead in Texas as scorching temps continue

Eli Lilly, Pfizer, and others want in on the online prescription market

focus

Gilead’s Trodelvy fails in lung cancer, raises questions on ADCs

Why Medicare shouldn’t cover every FDA

NIH director takes cautious approach to Biden drug pricing priority

Philips to halt sales of sleep apnea machines in U.S.

The latest on Bluebird gene therapies, Vertex's pain drug, and ADC FOMO

Wegovy leads to weight loss. Can it treat depression, too?

focus

knowledge

focus

focus